NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Provista Diagnostics today announced the closing of a financing round bringing in $6 million. 

Funding from the Series A-2 Preferred financing round came from existing investors exercising warrants from a previous financing round, the New York-based company said, adding that proceeds will be used for continued commercial development, prospective clinical trials, key management hires, and general corporate purposes. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.